Cancer in pregnancy: results of a series of 32 patients.

Sara De Carolis, Filomena Grimolizzi, Serafina Garofalo, Gabriella Fatigante, Sergio Ferrazzani, Brigida Carducci, Anna Maria Caruso

Risultato della ricerca: Contributo in rivistaArticolo in rivista

14 Citazioni (Scopus)


Cancer complicates approximately 1 in 1000 pregnancies. In pregnancy management, whether the benefits outweigh the risks derived from therapy must be carefully considered. MATERIALS AND METHODS: Thirty-two pregnant patients with the diagnosis of malignancy were followed. The indications and timing for surgery, chemotherapy, radiotherapy or delayed treatment were decided according to the malignancy characteristics and gestational age. The patient's consent was obtained before every decision. RESULTS: The rate of live births, premature deliveries, foetal abnormalities and neonatal deaths was 97%, 82%, 9% and 3%, respectively. Three women (9%) died during puerperium because of disease progression. CONCLUSION: The cancer treatment took into full consideration the specific condition of each pregnant patient. A good rate of live births was observed, even if a high rate of preterm delivery occurred. The management of malignancy required a team of experts in order to optimise every available choice for maternal health and neonatal well-being.
Lingua originaleEnglish
pagine (da-a)2413-2418
Numero di pagine6
RivistaAnticancer Research
Stato di pubblicazionePubblicato - 2006


  • cancer in pregnancy


Entra nei temi di ricerca di 'Cancer in pregnancy: results of a series of 32 patients.'. Insieme formano una fingerprint unica.

Cita questo